跳至主要内容
临床试验/ITMCTR2200005890
ITMCTR2200005890招募中未知

To explore the application value of high frequency ultrasound in evaluating the effect of Simiao powder in the treatment of gouty arthritis based on the study of histopathology and multi-omics

Guang'anmen Hospital of China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
20 至 60(—)
性别
All

入选标准

  • 1) The disease diagnosis meets the 2015 ACR/EULAR gout classification criteria;
  • 2) The first visit was in the acute stage of gout (the attack time was less than 7 days), with knee joint swelling and pain as the main joint symptom;
  • 3) Ultrasound examination showed clear knee joint effusion, synovial membrane, double track sign or crystal deposition or tophi;
  • 4) Meet the diagnostic criteria of TCM syndromes of damp-heat accumulation syndrome;
  • 5) Age between 20-60 years old.
  • 6) Voluntarily participate in the trial and sign the informed consent.

排除标准

  • 1) Patients with gout caused by certain drugs (such as proton pump inhibitors, low-dose aspirin, etc.), tumor radiotherapy and chemotherapy, etc. or secondary to diseases such as kidney disease, blood disease, and xanthine urethral deposition;
  • 2) The first diagnosis is in the non-acute stage of gout;
  • 3) Combined with other rheumatic diseases such as osteoarthritis and rheumatoid arthritis;
  • 4) Those with other knee joint diseases: such as knee joint septic arthritis, knee joint traumatic arthritis, etc.;
  • 5) Acute exacerbated or poorly controlled chronic diseases such as hypertension, coronary heart disease, liver and kidney insufficiency;
  • 6) Mental illness, lack of self-control, unable to express accurately or unable to cooperate with treatment.
  • 7) Those with abnormal coagulation function.

研究者

相似试验